Andros Pharmaceuticals
TWD32.00
0
-TWD0.30-0.93% 06:52 Today
Statistics
Day High
32.4
Day Low
31.05
52W High
45.95
52W Low
19.5
Volume
398,213
Avg. Volume
382,031
Mkt Cap
1.77B
P/E Ratio
-
Dividend Yield
-
Dividend
-
Financials
-969.29%Profit Margin
Unprofitable5.55MRevenue
-53.78MNet Income
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Andros Pharmaceuticals Co., Ltd. operates as a biopharmaceutical enterprise, concentrating on the advancement of novel drug delivery platform technologies. Its development pipeline features APC101, a metered-dose, quick-drying, film-forming spray undergoing Phase IIa clinical investigation for the management of pain linked to post-herpetic neuralgia. Also in development is APC201, an innovative topical anesthetic formulation currently in Phase I/II trials for Osteoarthritis treatment, alongside an siRNA (small interfering RNA) compound functioning as an antisense oligonucleotide and DNA candidate. In the preclinical phase, the company is advancing APC310 and APC501, both intended as anesthetics for intravenous catheter insertion and venipuncture. Another preclinical asset, APC401, is a specialized emulsified solution targeting post-surgical pain relief. Beyond its developmental programs, Andros Pharmaceuticals also provides LALP cream for dermal analgesic use, iMinos solution for treating Alopecia Androgenetica, and T4 endonuclease V. Established in 2008, the firm maintains its headquarters in Zhubei, Taiwan.
Show More
CEO
Ming-Wen Lee
Employees
15
Country
Taiwan
ISIN
TW0006917008
Listings
0 Comments
Share your thoughts
FAQs
What is Andros Pharmaceuticals stock price today?▼
The current price of 6917.TWO is TWD32.00 TWD — it has decreased by -0.93% in the past 24 hours. Watch Andros Pharmaceuticals stock price performance more closely on the chart.
What is Andros Pharmaceuticals stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Taiwan OTC Exchange exchange Andros Pharmaceuticals stocks are traded under the ticker 6917.TWO.
Is Andros Pharmaceuticals stock price growing?▼
6917.TWO stock has risen by +0% compared to the previous week, the month change is a -7.25% fall, over the last year Andros Pharmaceuticals has showed a +57.25% increase.
What is Andros Pharmaceuticals market cap?▼
Today Andros Pharmaceuticals has the market capitalization of 1.77B
What is Andros Pharmaceuticals revenue for the last year?▼
Andros Pharmaceuticals revenue for the last year amounts to 5.55M TWD.
What is Andros Pharmaceuticals net income for the last year?▼
6917.TWO net income for the last year is -53.78M TWD.
How many employees does Andros Pharmaceuticals have?▼
As of November 3, 2026, the company has 15 employees.
In which sector is Andros Pharmaceuticals located?▼
Andros Pharmaceuticals operates in the Health & Wellness sector.
When did Andros Pharmaceuticals complete a stock split?▼
Andros Pharmaceuticals has not had any recent stock splits.
Where is Andros Pharmaceuticals headquartered?▼
Andros Pharmaceuticals is headquartered in Zhubei, Taiwan.